Week 3
Week 3
) of those numbers.
ease quickly at first then more slowly.
own instead.
The 19th Hole
Month Price Demand (00s)
1 450 45
2 300 103
3 440 49
4 360 86
5 290 125
6 450 52
7 340 87
8 370 68
9 500 45
10 490 44
11 430 58
12 390 68
$10
$8
$6
$4
$2
$-
200 300 400 500 600 700 800
Go to the Chart Design tab and click Add Chart Element. Or, click the plus sign (+) at the top right corner of the
chart.
Click Trendline.
Select More Trendline Options from the bottom of the drop-down menu that appears.
Examine and select one of the trendline options: exponential, linear, logarithmic, polynomial, or power. You can
refer to the table below, or use the small pictures next to each option as a guide for the type of trendline that will
best fit the shape of your data. When you select a trendline, it will appear on the chart.
Check the box next to Display Equation on chart. The equation will then appear on the chart.
If the equation is in the middle of the chart, it is usually hard to read, so you can click and drag it to a clear area on
the chart.
best fit the shape of your data. When you select a trendline, it will appear on the chart.
Check the box next to Display Equation on chart. The equation will then appear on the chart.
If the equation is in the middle of the chart, it is usually hard to read, so you can click and drag it to a clear area on
the chart.
Assuming the unit cost of producing a set of clubs is $250, and the price must be a multiple of $10, what price should the
company charge to maximize its profit?
How does the optimal price depend on the unit cost of producing a set of clubs?
Demand vs price
140
120
80
Demand
60
40
20
0
250 300 350 400 450 500 550
Price
Power model
One way Data table Two way table
he chart.
stimated relationship to
500 550
Eponential Model
9.27%
1.06%
5.49%
10.33%
12.46%
5.44%
2.04%
7.87%
14.90%
8.51%
6.31%
2.39%
7.17%
Exponential Model
One way Data table Two way table
Scenario
A large drug company, Gopher Drugs, is deciding whether one of its new drugs, Iguazu, is worth pursuing. Iguazu is in the fina
to be incurred at the beginning of year 1, is $9.3M. The company estimates that the demand for Iguazu will gradually grow an
minus cost) to be $1.2M in year 1, then to increase at an annual rate of 10% through year 8, and finally to decrease at an annu
assuming its cash flows, other than the initial development cost, are incurred at the end of the respective years. Using an ann
the following questions:
Is the drug worth pursuing, or should Gopher Drugs abandon it now and not incur the $9.3M development cost?
How do changes in the model change the answer to the prior question?
Cost Cashflow
Final cost 9.3 Year 1 End of yearGross margin
life time 20 Years 1 $ 1.20
gross margins 1.2 Year 1 2 $ 1.32
Increse Year 8 3 $ 1.45
Increse rate 10% Year 8 4 $ 1.60
Decrese rate 5% Year 20 5 $ 1.76
discount rate 12% 6 $ 1.93
7 $ 2.13
(N)PV ₹ 11.85 =NPV(B9,F4:F23) 8 $ 2.02
Final cost 9.3 Year 1 9 $ 1.92
NPV ₹ 2.55 =B11-B12 10 $ 1.82
11 $ 1.73
12 $ 1.64
13 $ 1.56
14 $ 1.48
15 $ 1.41
16 $ 1.34
17 $ 1.27
18 $ 1.21
19 $ 1.15
20 $ 1.09
(N)PV $ -
ed on net present value (NPV). Read the problem below carefully. If you’d like, take notes and start setting up a spreadsheet model of you
azu, is worth pursuing. Iguazu is in the final stages of development and will be ready to enter the market one year from now. The final co
e demand for Iguazu will gradually grow and then decline over its useful lifetime of 20 years. Specifically the company expects its gross m
gh year 8, and finally to decrease at an annual rate of 5% through year 20. Gopher Drugs wants to develop a spreadsheet model of its 20-y
e end of the respective years. Using an annual discount rate of 12% for purposes of calculating net present value (NPV), the drug company
Cashflow
ross margin
=B5
=IF(E5<$B$6, F4*(1+$B$7),F4*(1-$B$8)) The XNPV Function
=IF(E6<$B$6, F5*(1+$B$7),F5*(1-$B$8)) There is another Excel function, XNPV, which can compu
cash flows occur at irregular times. Like the NPV functio
=IF(E7<$B$6, F6*(1+$B$7),F6*(1-$B$8)) discount rate and the values of the cash flows. Then, th
=IF(E8<$B$6, F7*(1+$B$7),F7*(1-$B$8)) also used as inputs. For more information on how to us
=IF(E9<$B$6, F8*(1+$B$7),F8*(1-$B$8)) XNPV function
(Microsoft Support).
=IF(E10<$B$6, F9*(1+$B$7),F9*(1-$B$8))
=IF(E11<$B$6, F10*(1+$B$7),F10*(1-$B$8))
=IF(E12<$B$6, F11*(1+$B$7),F11*(1-$B$8))
=IF(E13<$B$6, F12*(1+$B$7),F12*(1-$B$8))
=IF(E14<$B$6, F13*(1+$B$7),F13*(1-$B$8))
=IF(E15<$B$6, F14*(1+$B$7),F14*(1-$B$8))
=IF(E16<$B$6, F15*(1+$B$7),F15*(1-$B$8))
=IF(E17<$B$6, F16*(1+$B$7),F16*(1-$B$8))
=IF(E18<$B$6, F17*(1+$B$7),F17*(1-$B$8))
=IF(E19<$B$6, F18*(1+$B$7),F18*(1-$B$8))
=IF(E20<$B$6, F19*(1+$B$7),F19*(1-$B$8))
=IF(E21<$B$6, F20*(1+$B$7),F20*(1-$B$8))
=IF(E22<$B$6, F21*(1+$B$7),F21*(1-$B$8))
=IF(E23<$B$6, F22*(1+$B$7),F22*(1-$B$8))
readsheet model of your own. Then, watch
Exponential model
a
Year No Average of Seasonally Adjusted Sales b
1 $ 150,781.17
2 $ 161,696.25
3 $ 175,688.83
4 $ 185,437.25
5 $ 196,728.17
6 $ 206,334.08
7 $ 215,657.67
8 $ 233,872.00
9 $ 248,748.25
10 $ 255,663.75
11 $ 261,272.42
12 $ 272,232.50
13 $ 288,987.50
14 $ 307,826.08
15 $ 323,823.08
16 $ 334,008.00
17 $ 328,780.33
18 $ 303,288.92
19 $ 323,964.17
20 $ 349,717.75
Cost $ 4,000,000.00
Revenue 0
Profit $ 4,000,000.00
Discount rate 5%
(N)PV ₹ 3,303,159.13
NPV ₹ -696,840.87
Percentage growth
0.0%
7.2%
8.7%
5.5% Average of Seasonally Adjusted Sales
6.1% $400,000.00
4.9%
$350,000.00
4.5% f(x) = − 210.200083542189 x² + 14850.3731829574 x + 130460.201900585
8.4% $300,000.00
6.4% $250,000.00
2.8%
$200,000.00
2.2%
4.2% $150,000.00
6.2%
$100,000.00
6.5%
5.2% $50,000.00
3.1% $-
-1.6% 0 5 10 15 20
-7.8%
6.8%
7.9%
4.6%
Y=ae^(bx)
158193
0.043 ABS
$ 165,143.67 9.5%
$ 172,399.73 6.6%
$ 179,974.61 2.4%
$ 187,882.32 1.3%
$ 196,137.47 0.3%
$ 204,755.34 0.8%
$ 213,751.86 0.9%
$ 223,143.67 4.6%
$ 232,948.13 6.4%
$ 243,183.38 4.9%
$ 253,868.35 2.8%
$ 265,022.79 2.6%
$ 276,667.33 4.3%
$ 288,823.51 6.2%
$ 301,513.81 6.9%
$ 314,761.69 5.8%
$ 328,591.65 0.1%
$ 343,029.28 13.1%
$ 358,101.26 10.5%
$ 373,835.48 6.9%
$ 1,999,826.70 4.8%
574 x + 130460.201900585
15 20 25
Financial Estimates for Potential Projects (in $millions)
Project Index Functional Area (FA) Partnership Percentage Capex Year 1 Capex Year 2
1 FA1 100% $ 250.00 $ 100.00
2 FA1 33% $ 500.00 $ 300.00
3 FA1 50% $ 100.00 $ 200.00
4 FA1 100% $ 750.00 $ 500.00
5 FA1 75% $ 200.00 $ 400.00
6 FA2 50% $ 1,000.00 $ 300.00
7 FA2 100% $ 750.00 $ 750.00
8 FA2 100% $ 800.00 $ 700.00
9 FA2 67% $ 400.00 $ 600.00
10 FA3 100% $ 100.00 $ 200.00
11 FA3 50% $ 700.00 $ 500.00
12 FA3 100% $ 1,500.00 $ 400.00
Project Index Functional Area (FA) Partnership Percentage Capex Year 1 Capex Year 2
1 FA1 100% $ 250.00 $ 100.00
2 FA1 33% $ 165.00 $ 99.00
3 FA1 50% $ 50.00 $ 100.00
4 FA1 100% $ 750.00 $ 500.00
5 FA1 75% $ 150.00 $ 300.00
Yearly Cost $ 1,115.00 $ 999.00
Project Index Functional Area (FA) Partnership Percentage Capex Year 1 Capex Year 2
6 FA2 50% $ 500.00 $ 150.00
7 FA2 100% $ 750.00 $ 750.00
8 FA2 100% $ 800.00 $ 700.00
9 FA2 67% $ 268.00 $ 402.00
Yearly Cost $ 1,518.00 $ 1,302.00
Project Index Functional Area (FA) Partnership Percentage Capex Year 1 Capex Year 2
10 FA3 100% $ 100.00 $ 200.00
11 FA3 50% $ 350.00 $ 250.00
12 FA3 100% $ 1,500.00 $ 400.00
Yearly Cost $ 1,850.00 $ 650.00
ROI
% Change Average
15%
0%
5%
10%
15%
20%
25%
30%
s)
Capex Year 3 NPV
$ 100.00 60 Annual revenue $ 50,000.00 M
$ 300.00 180 Total exp $ 10,000.00 M
$ 400.00 80 Yearly cap $ 4,000.00 M
$ 300.00 310 Discount rate 12%
$ 800.00 220
$ 300.00 180
$ 300.00 410
$ 600.00 280
$ 800.00 380
$ 400.00 100
$ 300.00 260
$ 400.00 340
Capex Year 3 NPV Total capex New NPV ROI Approval Rating
$ 100.00 60 $ 450.00 53 0
$ 99.00 180 $ 363.00 158 14% 1
$ 200.00 80 $ 350.00 70 10% 1
$ 300.00 310 $ 1,550.00 273 18% 1
$ 600.00 220 $ 1,050.00 194 14% 1
$ 1,199.00 $ 3,313.00
Capex Year 3 NPV Total capex New NPV ROI Approval Rating
$ 150.00 180 $ 800.00 158 10% 1
$ 300.00 410 $ 1,800.00 361 20% 1
$ 600.00 280 $ 2,100.00 246 0
$ 536.00 380 $ 1,206.00 334 19% 1
$ 986.00 $ 3,806.00
Capex Year 3 NPV Total capex New NPV ROI Approval Rating
$ 400.00 100 $ 700.00 88 0
$ 150.00 260 $ 750.00 229 15% 1
$ 400.00 340 $ 2,300.00 299 13% 1
$ 550.00 $ 3,050.00
ROI
Minimum Maximum
10% 20%